Avid Bioservices Inc (CDMO)

[senrex]

Jazz, I've remained invested in PPHM largely due to your excellent (no, magnificent) scientific analysis. As I've said before, science is not enough (as I've discovered painfully from two other companies: METRICOM and FUSE). Both had new and cutting edge technology; neither had the management to bring shareholders value after long years of investment. PPHM will be no different. Will the science survive? No doubt. Will the PPHM shareholders benefit? Not a chance, friend.

Ironically, if the DTRA contract had not been in the making, the pending catastrophe next week would not have happened as quickly as we will soon witness. But being assured by management that not just the original funding plan -- but an even BIGGER deal was in the works from DTRA, well, this will be used by big pharma to wrestle this science from PPHM with very little recompense for you and me.

I don't fault management for the latest disappointment, but I do bitterly condemn them for years of ineptitude which has placed us in this spiral toward oblivion. Without $, Jazz, this science cannot be developed by this company -- period.